NewEdge Advisors’s iRadimed IRMD Stock Holding History

NewEdge Advisors’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.41M	Buy	25,254 +8,063	+47%	+$734K	0.01%	1117
2026 Q1	$1.65M	Sell	17,191 -65	-0.4%	-$6.5K	0.01%	1203
2025 Q4	$1.68M	Buy	+17,256	New	+$1.48M	0.01%	1163
2025 Q1	–	Sell	-3	Closed	-$165	–	4041
2024 Q4	$165	Hold	3	–	–	﹤0.01%	3755
2024 Q3	$151	Hold	3	–	–	﹤0.01%	3697
2024 Q2	$132	Buy	+3	New	+$128	﹤0.01%	3674
2023 Q2	–	Sell	-132	Closed	-$5.2K	–	3561
2023 Q1	$5.2K	Hold	132	–	–	﹤0.01%	2760
2022 Q4	$4	Buy	+132	New	+$3.78K	﹤0.01%	3846

Other funds holding IRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NewEdge Advisors's IRMD Position: Q2 2026 in Review

NewEdge Advisors increased its iRadimed (IRMD) stake by 47% in Q2 2026, buying an estimated $734K and bringing the position to 25,254 shares worth $2.41M. The position accounts for 0.01% of the portfolio, ranked #1117.

NewEdge Advisors first reported a position in IRMD in Q4 2022 and has held it in 8 quarters since. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

NewEdge Advisors held 25,254 shares of iRadimed worth $2.41M as of Q2 2026.
NewEdge Advisors bought 8,063 iRadimed shares in Q2 2026, an estimated $734K.
iRadimed made up 0.01% of NewEdge Advisors's portfolio in Q2 2026, its #1117 holding.
NewEdge Advisors first reported a position in iRadimed in Q4 2022 and has held it in 8 quarters since.
214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.